00:18:03 EDT Tue 01 Jul 2025
Enter Symbol
or Name
USA
CA



News for C:SVA from 2024-07-02 to 2025-07-01 - 37 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2025-06-16 19:41C:SVASernova Biotherapeutics Inc0.16Street WireSernova ex Haghighat pleads not guilty
2025-06-13 16:30C:SVASernova Biotherapeutics Inc0.165SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-06-13 16:30C:SVASernova Biotherapeutics Inc0.165SEDAR Interim MD & ASEDAR Interim MD & A
2025-06-02 20:26C:SVASernova Biotherapeutics Inc0.17News ReleaseSernova appoints Rigby as interim chair
2025-05-26 02:26C:SVASernova Biotherapeutics Inc0.195News ReleaseSernova chair Haghighat resigns
2025-05-23 19:00C:SVASernova Biotherapeutics Inc0.195Street WireSernova's Haghighat charged for insider trading
2025-05-22 14:58C:SVASernova Biotherapeutics Inc0.22News ReleaseSernova Biotherapeutics forms clinical advisory board
2025-05-14 15:52C:SVASernova Biotherapeutics Inc0.21News ReleaseSernova talks interim data from Cell Pouch trial
2025-04-17 17:09C:SVASernova Biotherapeutics Inc0.20News ReleaseSernova closes $4-million term loan from Navigate
2025-04-15 18:48C:SVASernova Biotherapeutics Inc0.18News ReleaseSernova to highlight Cell Pouch organ at Rome meeting
2025-04-01 17:17C:SVASernova Biotherapeutics Inc0.165News ReleaseSernova to continue to Cohort C T1D trial in H2 2025
2025-03-14 16:03C:SVASernova Biotherapeutics Inc0.175SEDAR Interim MD & ASEDAR Interim MD & A
2025-03-14 15:58C:SVASernova Biotherapeutics Inc0.175SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-03-10 17:13C:SVASernova Biotherapeutics Inc0.185News ReleaseSernova appoints Calias as CDO, R&D head
2025-03-05 12:32C:SVASernova Biotherapeutics Inc0.19News ReleaseSernova arranges $1-million debenture financing
2025-03-03 19:48C:SVASernova Biotherapeutics Inc0.20News ReleaseSernova receives FDA clearance for IND application
2025-02-07 18:04C:SVASernova Corp0.21Change NameSernova name change to Sernova Biotherapeutics
2025-02-03 18:58C:SVASernova Corp0.205News ReleaseSernova applies for investigational new drug to FDA
2025-01-30 16:44C:SVASernova Corp0.21News ReleaseSernova appoints Haghighat as chair
2025-01-13 11:37C:SVASernova Corp0.225News ReleaseSernova shareholders elect six directors at ASM
2024-12-23 17:34C:SVASernova Corp0.22SEDAR Annual Information FormSEDAR Annual Information Form
2024-12-23 17:27C:SVASernova Corp0.22SEDAR MD & ASEDAR MD & A
2024-12-23 17:21C:SVASernova Corp0.22SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-12-20 16:42C:SVASernova Corp0.23News ReleaseSernova reschedules AGSM to Jan. 10
2024-12-02 18:35C:SVASernova Corp0.22News ReleaseSernova enters product development LOI in Saudi Arabia
2024-10-11 09:27C:SVASernova Corp0.26News ReleaseSernova appoints Parsons as CFO
2024-09-19 09:49C:SVASernova Corp0.245News ReleaseSernova appoints Paterson to board
2024-09-16 16:46C:SVASernova Corp0.245SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-09-16 16:46C:SVASernova Corp0.245SEDAR Interim MD & ASEDAR Interim MD & A
2024-09-13 08:06C:SVASernova Corp0.255In the NewsGlobe says Leede's Loe rates Sernova "speculative buy"
2024-09-12 15:38C:SVASernova Corp0.295News ReleaseSernova talks data from Cell Pouch phase I/II trial
2024-09-04 10:24C:SVASernova Corp0.275News ReleaseSernova closes $5.2-million private placement
2024-08-29 13:54C:SVASernova Corp0.26News ReleaseSernova's financing overubscribed at $4.7-million
2024-08-20 10:05C:SVASernova Corp0.215News ReleaseSernova arranges $4-million private placement
2024-08-15 07:00C:SVASERNOVA CORP. J0.23News ReleaseLead Investigator for Sernova's Clinical Trial with Cell Pouch for Type 1 Diabetes to Deliver Oral Presentation at the 2024 EASD Annual Meeting
2024-08-12 15:24C:SVASernova Corp0.245News ReleaseSernova appoints Rigby as CEO
2024-07-15 10:16C:SVASernova Corp0.305News ReleaseSernova names Rigby executive chairman